https://www.selleckchem.com/pr....oducts/lomeguatrib.h
In the era of direct-acting antiviral therapies, hepatitis C positive organs offer a strategy to expand the donor pool. Heart failure patients with concomitant renal insufficiency benefit from combined heart/kidney transplant. In 2017, we began utilizing organs from hepatitis C donors for heart/kidney transplants. Characteristics and outcomes of heart/kidney transplants were collected at our institution from 2012 through 2019. We determined patient cohorts by donor hepatitis C antibody status, antibody positive (HCV+) versus antibod
Like
Comment
Share
